The QualityStocks Daily Stock List
- Spearmint Resources, Inc. (SPMTF)
- Body and Mind, Inc. (BMMJ)
- Parallax Health Sciences, Inc. (PRLX)
- Quanta, Inc. (QNTA)
- Simlatus Corporation (SIML)
- All for One Media Corp. (AFOM)
- Prize Mining Corporation (PRZFF)
- Geospatial Corp. (GSPH)
- Northstar Electronics, Inc. (NEIK)
- ProBility Media Corporation (PBYA)
- Nutra Pharma Corp. (NPHC)
- Petrolia Energy Corp. (BBLS)
- Spotlight Innovation, Inc. (STLT)
- RepliCel Life Sciences, Inc. (REPCF)
Spearmint Resources, Inc. (SPMTF)
Junior Mining Network, InvestorX, MarketSmart Resources, Investing News, Morningstar, Geology for Investors, Investment Pitch, 4-Traders, Stockwatch, Stockhouse, MarketWatch, Trading View, Wallet Investor, and Dividend Investor reported previously on Spearmint Resources, Inc. (SPMTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Spearmint Resources, Inc. acquires, explores, and evaluates mineral properties in the USA and Canada. An exploration stage enterprise, the Company’s emphasis is on assembling a portfolio of low risk, high reward properties at the exploration stage and developing them to maximize shareholder value. The Company previously went by the name Indefinitely Capital Corp. It changed its name to Spearmint Resources, Inc. in February of 2012. Spearmint Resources has its head office in Vancouver, British Columbia (BC).
The Company’s current projects include a portfolio of prospects in the Golden Triangle of BC; the 'Golden Triangle Gold Prospects' comprising six claims consisting of 9,157 acres bordering GT Gold Corp, the 920 acre 'NEBA West' & 6,803 acre 'NEBA' Gold-Copper Prospects bordering Aben Resources Ltd, the 'Henry' Gold-Copper Prospect comprising two contiguous claim blocks totaling 4,912 acres in the direct vicinity of Golden Ridge Resources Ltd., and the 17,593 acre 'EL North' Nickel-Copper Prospect comprising six contiguous claims in the Eskay Creek Camp bordering Garibaldi Resources Corp.
Spearmint Resources current projects also include its recent acquisition, the 4,980 acre 'Prickle' property bordering Brixton Metals Corp. The Company’s other BC projects include the 'Gold Mountain Prospects' comprising three separate claim blocks totaling 1,245 acres bordering Barkerville Gold Mines, the 'Safari' Copper-Gold Prospect consisting of 9,007 contiguous acres in the northern Quesnel Trough in north-central BC directly bordering Serengeti Resources, Inc., and the 'Hammernose' Gold Prospect consisting of 5,140 acres directly bordering the strategic alliance between Westhaven Ventures, Inc. & Sable Resources Ltd. in the Spences Bridge Gold Belt in Southern BC.
Additionally, current projects include the 'Chibougamau Vanadium Prospects' consisting of 17,142 contiguous acres bordering the vanadium deposit of BlackRock Metal's (private) Ilmenite vanadium project and Vanadium One Energy Corp. and Spearmint's 'Clayton Valley Lithium Prospects' in Nevada comprising two claim blocks totaling 1,160 acres bordering Pure Energy Minerals & Cypress Development Corp. where Spearmint's drill results have intersected Lithium values as high as 1,670 ppm Li.
Spearmint Resources announced this past April that it acquired the 'El North 3' claims package. The new acreage will result in a contiguous land package totalling 17,593 acres bordering Garibaldi Resources Corp. in the Golden Triangle of BC. Spearmint has also recently acquired the Perron-East Gold Prospects consisting of 4 mineral claim blocks encompassing 2,862 acres located in the Abitibi greenstone belt of northwestern Quebec.
In late October, Spearmint Resources announced that it encountered positive indicators on its "Safari" copper-gold prospect consisting of 9,007 contiguous acres in the northern Quesnel Trough in north-central BC. Rock sampling completed by the Company during 2019 was designed to confirm and follow up on the Kiska results. A total of 2 of the 17 rock grab samples collected during 2019 returned values of 0.23% and 0.14% copper; in addition to anomalous gold and silver values of 0.3 grams-per-tonne (g/t) gold, and 2.7 and 1.0 g/t silver.
Spearmint Resources, Inc. (SPMTF), closed Tuesday's trading session at $0.0143, even for the day, on 111,000 volume. The average volume for the last 3 months is 26,270 and the stock's 52-week low/high is $0.001099999/$0.075699999.
Body and Mind, Inc. (BMMJ)
New Cannabis Ventures, Penny Stock Tweets, Midas Letter, Insider Financial, Dividend Investor, Wallmine, Market News Updates, PotStockNews, Investor Ideas, Stockhouse, MicroSmallCap, Wallet Investor, GuruFocus, Trading View, Simply Wall St, and InvestorsHub reported beforehand on Body and Mind, Inc. (BMMJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Body and Mind, Inc. invests in high quality medical and recreational cannabis cultivation, production and retail. Its wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licences. In addition, Body and Mind holds cultivation and production licenses. Body and Mind (BaM) products include dried flower, edibles, topicals, extracts, and GPEN Gio cartridges. Body and Mind is based in Vancouver, British Columbia. Nevada Medical Group LLC (NMG Nevada) is a wholly-owned subsidiary of Body and Mind.
Body and Mind has collected, for many years’, elite cannabis plants from around the world. Through carefully crossbreeding these plants, it has developed strains that give what it states are the perfect balance of body and mind benefits. Its cannabis plants are grown with hands-on care in small batches. Moreover, the Company never uses synthetic pesticides. It offers an assortment of strains, available in flower, vapes, pre-rolls, as well as concentrates.
Body and Mind has expanded into Arkansas with in-State partner, Comprehensive Care Group LLC (CCG). The companies will work together to develop a medical marijuana dispensary facility in West Memphis, Arkansas. Medical marijuana dispensaries in Arkansas are licensed for retail sales and cultivation of up to 50 plants within the same facility.
Body and Mind signed a long term lease to relocate its production facility to a new campus within one mile of the Pepper Lane cultivation facility. The new facility is approximately 7,500 square feet. Body and Mind’s plan is to move the current production licence. It will not need to apply for a new license to produce edibles, oils and extracts.
Body and Mind has started manufacturing in California via the Body and Mind California subsidiary NMG Cathedral City (NMG). The Cathedral City facility has been producing THC (Tetrahydrocannabinol) distillate in bulk form since June 2018. The facility is planned to be outfitted to manufacture popular Body and Mind products. This includes oils, wax, live resin, ambrosia, and edibles.
This past September, Body and Mind (BaM) announced that Satellites Dip, LLC's (SD) Cathedral City, California facility, which is fully managed by BaM pursuant to the management and administrative services agreement entered into between SD and BaM, started shipping BaM's award-winning products in California that are manufactured by SD pursuant to a license agreement between BaM's wholly-owned subsidiary, Nevada Medical Group, LLC and SD. This follows after the Cathedral City facility received final testing and California packaging compliance certifications for BaM's products.
Last month, Body and Mind updated shareholders on the construction of its fully funded medical marijuana dispensary in West Memphis, Arkansas. The facility is being developed with its in-state partner, Comprehensive Care Group LLC ("CCG").
The project is moving ahead with all pre-construction activities having been completed. Considerable construction progress has been made, with interior framing 90 percent complete in the dispensary and cultivation areas. Work is in-progress on roughing in chase ways for power upgrades. Electrical rough in remains ongoing throughout the project. Furthermore, HVAC ductwork is 90 percent complete in the dispensary area.
Body and Mind, Inc. (BMMJ), closed Tuesday's trading session at $0.76, up 2.1231%, on 68,514 volume with 57 trades. The average volume for the last 3 months is 64,167 and the stock's 52-week low/high is $0.354699999/$2.70000004.
Parallax Health Sciences, Inc. (PRLX)
Market Screener, GlobeNewswire, Last10k, Wallmine, 4-Traders, TMXmoney, PR Newswire, Simply Wall St, Wallet Investor, Stockwatch, Proactive Investors, TradingView, InvestorsHub, and Stockhouse reported previously on Parallax Health Sciences, Inc. (PRLX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Parallax Health Sciences, Inc. is an outcome-driven connected healthcare company based in Santa Monica, California. It allows for cost-effective remote diagnosis, treatment and monitoring of patients through proprietary platforms of integrated products and services. Its products and offerings capitalize on the digital transformation in healthcare for improved patient compliance, diagnosis and treatment, and support healthcare system cost savings and efficiencies. Parallax Health Sciences lists on the OTC Markets Group’s OTCQB.
Parallax Health Sciences focuses on personalized patient healthcare through its wholly owned subsidiaries, Parallax Health Management, Parallax Behavioral Health, and Parallax Diagnostics. Parallax’s interoperable novel applications provide patients point-of-care testing and monitoring with information communicated via internet-based mobile phone applications, which are agnostic as to operating system. They are built on highly sophisticated data analytics.
Information is retrieved real-time by physicians who are monitoring patients with chronic diseases or through biometric feedback for health-related behavior modification. Information is automated for integration into electronic health records (EHR).
Parallax Health Management offers remote monitoring solutions. These solutions are to support disease management and provide better care options for chronic conditions. Parallax Behavioral Health (PBH) provides consulting and software solutions to businesses and individuals. This is to improve value, margin, and performance via enhanced outcomes and lower cost mastery. PBH has its patented Intrinsic Code. It includes predictive - progressive analytics and goal optimization software. PBH is strategically positioned to enable users from large healthcare corporations to individuals take control of their outcomes.
Pertaining to Parallax Diagnostics, Parallax's Target Antigen Detection System (TADS) Diagnostic Platform is a Controlled Flow-Through Rapid Immunoassay Technology. It offers an assortment of improved modifications and features to the traditional Flow-Through Immunoassay Test. With its Platform uniformity, vacuum pump, absorption layer for sample overflow, and complete compatibility with the Company’s optic reader, the Target System Diagnostics Platform is an innovative collection of tests for qualitative and quantitative detection of patient conditions.
Today, Parallax Health Sciences announced that its wholly-owned subsidiary Parallax Behavioral Health entered into vertical market licenses and technology integration agreements within the financial technology, human resource, lifestyle and healthcare fields.
Mr. Paul Arena, Chief Executive Officer of Parallax Health Sciences, said, ”Our data driven outcomes technology has application within several identified fields of use and we are fulfilling our commitment to our intellectual property monetization strategy by generating high gross margin revenue through licensing and enabling leading organizations with our technology to maximize our shareholder value.”
Parallax Health Sciences, Inc. (PRLX), closed Tuesday's trading session at $0.104, up 3.8961%, on 45,591 volume with 5 trades. The average volume for the last 3 months is 71,072 and the stock's 52-week low/high is $0.054000001/$0.279900014.
Quanta, Inc. (QNTA)
Zacks, TradingView, BioSpace, Investor Ideas, Market Screener, Stockopedia, Last10k, and Simply Wall St reported previously on Quanta, Inc. (QNTA), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Quanta, Inc. is an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to boost performance within the human body. Its proprietary technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. Quanta specializes in potentiating rare, naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Established in 2016, Quanta is headquartered in Los Angeles, California. The Company lists on the OTC Markets.
Quanta offers its technology as a platform to product makers by way of distribution channels and consumer products. It serves brands in cannabis, anti-aging, health and wellness, stress management, pain management, fitness and brain performance enhancement.
Quanta’s CBD (cannabidiol) pain relief rub is an all-natural CBD topical that consists of 13 natural elements. These include turmeric, arnica and polarized CBD. The design is to provide relief from pain, inflammation, and also stiffness in muscles and joints.
Quanta has partnered with Kapno to sell the Company's CBD Muscle Rub and CBD Vape. Kapno distributes brands online via its existing worldwide network. Kapno has 2.4 billion followers across all social platforms.
Quanta CBD Muscle Rub is a premium organic and the balm works to increase circulation, ease aches and pains, and provide maximum relief, comfort, and overall well-being. Quanta has since launched three additional products to assist in their mission with the aforementioned CBD Vape, Muscle Rub PLUS, and Sensitive Skin version of their flagship Muscle Rub.
Quanta products have gained a loyal following month over month, with the online repurchase rate, which grew to 26.8 percent in Q2, along with seeing their B2B (Business to Business) customers, grow at a rate of 119.2 percent over Q1. The Company announced in its Q2 filing that sales for its patented polarized products grew at a 37.8 percent rate quarter over quarter.
Quanta, Inc. (QNTA), closed Tuesday's trading session at $0.30, off by 14.0401%, on 7,332 volume with 11 trades. The average volume for the last 3 months is 30,707 and the stock's 52-week low/high is $0.200000002/$19.00.
Simlatus Corporation (SIML)
Zacks, Emerging Growth, Stock Scores, Stockaholics, Stockwatch, Stock Target Advisor, Financial Buzz, Wallet Investor, Marketbeat, Real Investment Advice, and Financial Insiders reported earlier on Simlatus Corporation (SIML), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
A holding company, Simlatus Corporation concentrates on opportunities in the cannabis space. The Company owns and operates several subsidiaries with multiple revenue streams in the CBD (cannabidiol) industry. Proscere Bioscience is the Company’s division focused on the CBD industry. Simlatus Corporation lists on the OTC Markets. The Company is headquartered in Grass Valley, California.
Simlatus’ diversity includes other subsidiaries, such as Satel Group. Satel is a premier high-rise DirecTV provider for the financial commercial and residential metropolitan San Francisco Bay area. In addition, its subsidiaries include Simlatus, a manufacturer of audio/video products that presently sells to DirecTV, CBS, Fox News and Warner Bros.
Simlatus manufactures and markets commercial High-Definition (HD) and Analog audio/video systems for the international broadcast studio industry. The Company continues to lead the commercial industry with high-end equipment. Its “SyncPal™ and Simlatus-IBS™ are for revolutionizing studio management and audio/video control using smartphones or smart glasses.
Regarding the Digital Media and Augmented/Virtual Reality device industry, the Company’s SocialCast AR and Augmented/Virtual Reality Content Server products will enable Simlatus to expand into high-growth digital television and over-the-top (OTT) markets. It is developing technologies in Virtual Reality, Augmented Reality, Audio/Video Codecs, Audio Content Recognition, and OTT API Integration.
Regarding the cannabis space, acquisitions of companies in the hemp sector are accelerating globally as industrial and consumer hemp/CBD markets develop. Mr. Richard Hylen, Simlatus Chairman and Chief Executive Officer, stated, “Legal marijuana is worth an estimated $50 billion for the U.S. today, and experts have projected the U.S. industry to skyrocket to $80 billion by 2030.
Simlatus has a firm standing in this industry with the manufacturing of its Cold-Water Extraction Systems required to fulfill the industry needs for THC, CBD and Hemp extraction. Cannabis legalization has swept across North America with 10 states plus Washington, D.C., that provide legalized recreational marijuana; and full legalization arrived in Canada in October 2018. Our subsidiary, Proscere Bioscience, is fulfilling its first order of $2.8M, and 5 year commitments from its global distribution of $275M. This is definitely a game changer for our company and our shareholders.”
Simlatus Corporation (SIML), closed Tuesday's trading session at $0.0003, up 52.2843%, on 331,398,472 volume with 207 trades. The average volume for the last 3 months is 138,416,446 and the stock's 52-week low/high is $0.00015/$0.100000001.
All For One Media Corp. (AFOM)
OTC Markets, MarketWatch, Global Energy Media, Central Charts, Simply Wall St, Pink Investing, Stock Digest, Penny Stock Tweets, Street Register, Stockhouse, Financial Content, Emerging Growth, The Street, Market Exclusive, InvestorsHub, Capital Network, Proactive Investors, and Barchart reported earlier on All For One Media Corp. (AFOM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
All For One Media Corp. is a tween marketing company listed on the OTC Markets’ OTCQB. Named “Generation I” for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media. Essentially, All For One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable. All For One Media has its head office in Mount Kisco, New York.
The Company is working to make the transition from a development stage corporation creating and acquiring media assets to a content provider launching many initiatives marketed to its core tween demographic. Its goal is to capitalize on a broad variety of potential revenue streams.
All For One Media, through entertainment, is working to deliver a message that will resonate with kids to impact the epidemic of bullying and cyber-bullying. In addition, it is working to help individuals who have been affected by bullying to deal with it in a positive and constructive manner.
All For One Media has produced Drama Drama (f/k/a "Crazy For the Boys"). Drama Drama is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. This film tells the story of five high school girls from five very different cliques who must work together to run their school’s anti-bullying organization. The film features original pop songs pertaining to peer pressure, unrequited love, and teen angst. The expectation is that Drama Drama will generate revenues from numerous sources.
The Company has completed production of Drama Drama. It has started to screen the movie for buyers. Moreover, it engaged William Morris/Endeavor Content (WME) as the exclusive sales agent for the film. WME represents artists across all media platforms, particularly movies, television, music, theatre, digital and publishing.
All for One Media is making plans to commence group activities for the launch of the band "Drama Drama" concurrent to the release of the movie. The release of a full-length film used to promote the launch of a pop group is an industry first. The Company has also started negotiations with a number of major record labels for distribution of the film soundtrack.
All For One Media Corp. (AFOM), closed Tuesday's trading session at $0.0015, up 11.1111%, on 13,393,983 volume with 104 trades. The average volume for the last 3 months is 371,032 and the stock's 52-week low/high is $0.00135/$0.104999996.
Prize Mining Corporation (PRZFF)
Investing News, The Street, Junior Mining Network, Science of Stocks, Small Cap Power, Stockhouse, Stock Market Watch, Market News Updates, Barchart, Wallet Investor, 4-Traders, OTC Markets, Business Insider, Trading View, and Penny Stock Hub reported previously on Prize Mining Corporation (PRZFF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Prize Mining Corporation explores for and develops mineral properties. The Company’s flagship project is the Manto Negro Copper Project (Coahuila, Mexico). Additionally, it has its Kena & Daylight Gold project. An exploration stage company, Prize Mining is based in Calgary, Alberta.
The Manto Negro Copper Project has sedimentary stratabound oxidized and reduced “Red Bed type” copper deposits. The Manto Negro property consists of 17,659 hectares. It includes more than 35 known occurrences of copper mineralization.
Prize Mining received the NI 43-101 Technical Report for the Manto Negro property in Coahuila, Mexico from geological consultants, Norwest Corporation of Calgary, Alberta. The Technical Report includes a review of the regional and local geology, mineralization types and grades, exploration history and results, overall mineral potential and recommendations for more work. The report does not include any estimate of mineral resources nor reserves.
The Kena & Daylight Gold project is a large property with first-rate infrastructure. This Property comprises 9,000 hectares in southeastern British Columbia. The Property is 10 kilometers from the Town of Nelson. The Gold Mountain Zone and Kena Gold Zone are a porphyry gold deposit with high grade zones.
The Kena Property has an NI 43-101 resource of an indicated 481,000 ounces of gold and an inferred 1,318,000 ounces of gold. The Daylight claims have four historical producing mines with grades as high as 37 g/t gold. The Company’s focus on the Daylight Property is on four large gold-bearing targets.
Prize Mining announced this past December that step-out diamond drill holes at the Pilar Grande area of the Manto Negro Copper Project continues to intersect copper-silver mineralization. Drilling at the El Granizo site encountered complex faulting that is yet to be completely interpreted as to the impact on mineralization.
Also in December, the Company reported results from the Phase I and II diamond drill programs from the Kena Gold Project, positioned in the highly prospective Kootenay Boundary area near Nelson, British Columbia. The focus of the exploration program at the Kena Gold Project has been on the Toughnut Property. Drilling on Toughnut has intersected significant near surface gold mineralization. The higher grade intercepts demonstrate the potential for a much larger gold system on Prize Mining’s property.
Recently, Prize Mining provided an update on the results and success of its Phase 1 diamond drilling program at the Manto Negro Copper Project.
Mr. Michael McPhie, Prize Mining’s President and Chief Executive Officer, said, "We are very pleased to announce the completion of and results from our Phase 1 exploration drilling program at the Manto Negro Copper Project. We have tested just a small part of our 18,000 hectare property that contains some 35 surface copper showings over a 40 kilometer trend. These results provide us with confidence in the scale, grade and potential of this district size property and will guide our focus in the Phase 2 program that will begin in the weeks ahead."
Prize Mining Corporation (PRZFF), closed Tuesday's trading session at $0.00825, up 52.7778%, on 34,501 volume with 5 trades. The average volume for the last 3 months is 20,726 and the stock's 52-week low/high is $0.0015/$0.119999997.
Geospatial Corp. (GSPH)
Penny Sleuth, Micro Cap Research, InvestorsHub, Market Screener, 4-Traders, Morningstar, MarketWatch, PR Newswire, GuruFocus, HotStockChat, YCharts, Wallet Investor, SmallCapVoice, Trading View, The Street, last10k, and Simply Wall St reported earlier on Geospatial Corp. (GSPH), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Geospatial Corp. is a leading innovator of asset management/analytics/mapping software and 3D mapping technologies. The Company utilizes integrated technologies to establish the accurate location and position of underground pipelines, conduits, and also other underground infrastructure data. This allows Geospatial to create accurate three-dimensional (3D) digital maps and models of underground infrastructure. Geospatial is headquartered in Sarver, Pennsylvania.
The Company has new Quality Assurance (QA) and Installed Locational Integrity Management (ILIM) programs for underground pipelines. Geospatial provides complete QA programs and ILIM programs for underground pipelines and conduits installed through Horizontal Directional Drilling (HDD) methods irrespective of depth, material, or soil conditions. The service addresses the need for accurate 3D mapping of critical pipeline segments, which exceeds regulatory requirements and supports integrity and reliability demands.
The Company provides integrated data acquisition technologies. These technologies accurately locate and map underground and aboveground infrastructure assets. This includes pipelines and surface features via Geospatial’s GeoUnderground Cloud-Based Portal. The design of GeoUnderground is around the Google Maps API.
GeoUnderground is the Company’s cloud-based Geographic Information System (GIS) platform. It provides clients with a total solution to their underground and aboveground asset management needs. Geospatial uses a collection of data acquisition tools. The Company cost-effectively maps most pipelines to an accuracy of less than 10 cm (3.9 inches).
GeoUnderground is a strong Cloud-Based GIS database. The database enables users to view and use this 3D pipeline mapping information securely from any desktop or mobile device. Geospatial is integrating Blockchain technology with GeoUnderground. This will provide a cloud-based locational software platform permitting energy companies a secure way to manage contracts, assure provenance, and track asset maintenance.
Recently, Geospatial announced that Kerr Engineered Sales and Geospatial entered into a sales and marketing agreement to provide underground mapping solutions, data acquisition and software solutions across the North East and Mid-Atlantic regions. Kerr Engineered Sales has been selling integrated solutions to major oil and gas transmission and distribution companies for decades. It has established a strong reputation representing many of the best technologies within the energy industry.
Geospatial Corp. (GSPH), closed Tuesday's trading session at $0.0195, up 46.6165%, on 2,946 volume with 2 trades. The average volume for the last 3 months is 70,190 and the stock's 52-week low/high is $0.0062/$0.0259.
Northstar Electronics, Inc. (NEIK)
Penny Stock Tweets, MarketWatch, Stockopedia, Hotstocked, Zacks, InvestorsHub, last10k, Proactive Investors, Financial Buzz, Front Page Stocks, MicroCapSpot, Business Wire, Stockhouse, The Street, YCharts, Capital Cube, Daily Stocks, Marketwired, GuruFocus, Wallet Investor, OTC Watch, and Market Screener reported previously on Northstar Electronics, Inc. (NEIK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Northstar Electronics, Inc. works in the aviation, defense, and marine industries. The OTCQB-listed Company has a wide-ranging history of developing and manufacturing defense and commercial electronic and mechanical systems. Established in the late 1990’s, Northstar Electronics is headquartered in Virginia Beach, Virginia. Northstar Electronics’ subsidiary is Northstar Sealand Enterprises Ltd. (NSEL).
The Company carried out design and manufacturing contracts for diverse divisions of Lockheed Martin Corp. Additionally, Northstar designed, manufactured, and sold its own sonar-based system to commercial customers.
Northstar Electronics has moved towards making and selling its own independent systems, since the end of the aforementioned contracts. At present, the Company is undergoing restructuring to move forward with a renewed emphasis on the development of a new aviation business and also carry out work to develop unique sonar systems.
Subsidiary NSEL is jointly owned by Northstar Electronics and Sealand Aviation Ltd. Both companies have many years of experience in working with certified commercial aircraft and government military contracts. NSEL is working to acquire the global rights to a “Turbo-Prop” single engine industrial airplane from an international leader in the aerospace industry. The timeline for the final agreement with the subsidiary company that owns the rights to the airplane has been extended.
The chief applications for the airplane are in “Agriculture and Rapid Response Forest Fire Fighting (RRFFF).” NSEL is continuing its evaluation of the “Cloud Seeding” market. Moreover, Northstar sees substantial potential in the field of Counter Insurgency (COIN). Company Management is exploring future possibilities in this sector.
Northstar Electronics is moving ahead with its expansion from being an aerospace contract manufacturer to becoming an “Original Equipment Manufacturer” (OEM) with its own products. The Company made significant progress in the purchase of the worldwide rights to a single engine “Turbo Prop” airplane from a major overseas aerospace company.
Recently, Northstar Electronics provided an update to its shareholders on an important milestone achieved by its subsidiary, Northstar Sealand Enterprises Ltd. (NSEL), on a major acquisition. Northstar Electronics and NSEL have been working closely with a major international Aerospace Company with the goal to acquire the international rights and IP (Intellectual Property) for a high-performance Turbo-Prop industrial aircraft.
The Aerospace Company recently presented the main details of this complex transaction to the Canadian government’s Industry, Science and Education Department (ISED). The plan was met with positive and enthusiastic feedback from the department’s representatives.
This confirmation of interest in the transaction, and its eligibility for considerable “Offset” credits under ISED’s Industry Trade and Benefits program, will now accelerate the planned transaction through the Aerospace Company’s internal review processes. Northstar Electronics is moving ahead with its plans to provide financial support for the endeavour. The Company is aligning key investors and financial instruments. NSEL continues its pre-sales efforts and its preparations for a fast and efficient ramp-up to production.
Northstar Electronics, Inc. (NEIK), closed Tuesday's trading session at $0.019, up 90.00%, on 9,631 volume with 4 trades. The average volume for the last 3 months is 66,573 and the stock's 52-week low/high is $0.003599999/$0.05.
ProBility Media Corporation (PBYA)
NetworkNewsWire, MarketWatch, Morningstar, Marketwired, Barchart, The Street, OTC Markets, Dividend Investor, InvestorsHub, StockTrot, Topstocksnews, Marketbeat, Penny Stock Hub, Wallmine, YCharts, Simply Wall St, and Stocks to Buy Now reported previously on ProBility Media Corporation (PBYA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
ProBility Media Corporation is a technology business offering immersive technologies, digital learning and compliance solutions for the education and training markets. The Company serves customers from the individual to the small business to the enterprise level corporation. In January 2018, ProBility Media acquired DISCO Learning Media, an online course developer and digital publisher.
ProBility Media has its head office in Houston, Texas, with offices in Florida, New York, and Vermont. ProBility Media is an education technology (EdTech) company. The Company’s shares trade on the OTC Markets.
The Company offers premier training courses and materials and works to prepare the workforce for excellence. It is executing the strategy of defragmenting the marketplace of thousands of disparate companies through acquiring smaller companies in the areas of its expertise and organically building revenue through synergies.
ProBility Media is looking for acquisition targets that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, and qc firms and additional vocational industries. ProBility, by way of its electrical training division, is becoming the largest wholesaler of electrical codes and exam prep material in the United States. In addition, through its construction training division, it offers programs in 22 states. This division serves one of the largest certification markets in the United States.
The Company’s DISCO Learning Media entered into an agreement to help The University of Texas System launch Careers in Chemistry, a new game-based experience inside Minecraft: Education Edition aimed at highlighting chemistry-related career opportunities to high school students. University of Texas at Austin associate professor of instruction in chemistry and science entertainer Dr. Kate Biberdorf will help guide the project and supervise the career curriculum.
Austin-headquartered education agency, DISCO Learning Media, provided instructional and media content support. DISCO Learning Media, a creative education agency, eCourse developer and digital publisher, is a division of Probility Media.
ProBility Media Corporation (PBYA), closed Tuesday's trading session at $0.0002, up 100.00%, on 100,000 volume with 1 trade. The average volume for the last 3 months is 3,450,809 and the stock's 52-week low/high is $0.000000999/$0.003.
Nutra Pharma Corp. (NPHC)
Serious Traders, PennyStocks24, StocksToBuyNow, Pumps and Dumps, Winston Small Cap, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, and Innovative Marketing reported earlier on Nutra Pharma Corp. (NPHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nutra Pharma Corp. is a biotechnology company listed on the OTC Markets. The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Nutra Pharma is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Founded in 2000, Nutra Pharma is based in Coral Springs, Florida.
By way of its subsidiaries, the Company carries out basic drug discovery research and clinical development. The focus of its approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, particularly those found in snake venom from the cobra.
Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was earlier granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. Nutra Pharma’s RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).
Additionally, Nutra Pharma looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS.
Nutra Pharma’s Designer Diagnostics subsidiary engages in the research and development (R&D) of diagnostic test kits designed to be used for the quick identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).
Nutra Pharma offers several drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The Company has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength. This is the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Moreover, the Company has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.
In September 2018, Nutra Pharma announced that its work with EuroAmerican IP, LLC resulted in a listing of its Nyloxin® product line on the website, www.GoVets.com. GoVets is the online marketplace under the National Veteran Small Business Coalition (NVSBC) to buy from VA-verified Service-Disabled Veteran-Owned Small Businesses (SDVOSBs).
With growing concern regarding consumers using opioid and acetaminophen-based pain relievers, Nyloxin® offers an alternative, which does not rely on opiates or non-steroidal anti-inflammatory drugs, known as NSAIDs, for their pain relieving effects. Nyloxin® has a well-defined safety profile.
Nutra Pharma Corp. (NPHC), closed Tuesday's trading session at $0.0003, up 50.00%, on 2,220,238 volume with 5 trades. The average volume for the last 3 months is 3,672,674 and the stock's 52-week low/high is $0.000199999/$0.000549999.
Petrolia Energy Corp. (BBLS)
Insider Monitor, MarketWatch, Stockhouse, InvestorsHub, Infront Analytics, Capital Cube, Stockflare, OTC Markets, 4-Traders, Simply Wall St, GuruFocus, TradingView, and Market Exclusive reported previously on Petrolia Energy Corp. (BBLS), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Petrolia Energy Corp.’s main concentration is employing inventive technology and the implementation of its own cutting-edge, proprietary technologies to improve the recoverability of existing oil fields. Its team of experts has a first-rate record of converting oil fields into compliant, producing, and profitable entities. Petrolia Energy’s primary goals are to locate undervalued assets, identify properties with resolvable environmental and mechanical issues, and lessen lift costs resulting in increased shareholder value. OTCQB-listed, Petrolia Energy is based in Houston, Texas.
The Company focuses on new oil wells in established areas of oil production. Petrolia has more than eight decades of operational and management experience throughout the energy industry. It announced in October 2016 that it purchased a 90 percent working interest (WI) via a purchase and sale agreement (PSA) and a share exchange agreement (SEA) with Jovian Petroleum Corp. and its subsidiaries, Jovian Resources, LLC and SUDS Properties, LLC, increasing its ownership to 100 percent WI for the Slick Unit Dutcher Sands (SUDS) field in Creek County, Oklahoma.
Petrolia Energy completed in 2017 the acquisition of a 60 percent net WI in the Twin Lakes San Andres Unit (TLSAU) lease, in Chaves County, New Mexico. This brings its total ownership of TLSAU to 100 percent. Overall, the TLSAU lease includes 4,864 gross and net acres; 2,292,903 barrels of 1P reserves; 44 existing vertical oil production wells, 12 that are now producing; 44 existing injection wells for water flood and/or CO2 injection for enhanced oil recovery (EOR); broad surface infrastructure, and a dedicated Caprock well to supply future water flood operations.
Petrolia Energy has signed the Slick Unit Exploration and Development Agreement with Boone Operating, Inc. to explore and develop the Misener and Simpson Formations at the Slick Unit Dutcher Sands Field (SUDS Field). Boone Operating is a private Exploration & Production company.
Petrolia Energy has also acquired a 25 percent Working Interest (WI) in the Luseland, Hearts Hill, and Cuthbert fields in southwest Saskatchewan and eastern Alberta. This acquisition consists of WIs in 64 sections (about 41,526 acres) with 240 oil and 12 natural gas wells producing on the properties. Additionally, there are several idle wells with potential for reactivation and 34 sections of undeveloped land (about 21,760 acres).
Petrolia Energy has centered its acquisition efforts in core regions in Texas, New Mexico and Oklahoma. The Company is also pursuing its strategy to offer low-cost operational solutions in established plays, including the Minerva-Rockdale shallow oil play in Texas, the Dutcher Sands play in Oklahoma and its San Andres play in New Mexico.
Petrolia Energy Corp. (BBLS), closed Tuesday's trading session at $0.0679, up 69.75%, on 100 volume with 1 trade. The average volume for the last 3 months is 6,086 and the stock's 52-week low/high is $0.039999999/$0.14.
Spotlight Innovation, Inc. (STLT)
Penny Picks, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to unique and proprietary platform technology candidates. Its emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.
The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. Spotlight Innovation is based in Urbandale, Iowa.
Spotlight Innovation’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is attained through its extensive relationships with numerous leading academic institutions and other sources. Spotlight provides value-added development capability and funding to expedite development progress.
The Company’s development pipeline includes product candidates for cancer, chronic pain, spinal muscular atrophy (SMA) and Zika virus infection. Spotlight works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. Additionally, it works to provide value-added development capability and funding to achieve fast IND approval to commence human clinicals for targeted Platform Technology Candidates.
Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive global rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.
Spotlight Innovation subsidiary Caretta Therapeutics has its chronic pain relief product Venodol Roll-on. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.
Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, started Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. Contract Research Organization (CRO) ImmunoClin Ltd. is supervising the study conduct.
Spotlight Innovation has entered into a multi-year partnership agreement with Hip-Hope, Inc. (Des Moines, Iowa-based), an organization committed to using arts and culture to promote, advocate and support hope for at-risk youth wherever symptoms of hopelessness are widespread.
As part of this partnership, Spotlight Innovation is the title sponsor for Hip-Hope’s 2018 “#kidslivesmatter FUNraiser Challenge” to take place August 3, 2018, at the 7 Flags Event Center in Clive, Iowa. The annual event is a youth empowerment campaign. The design of it is to build kids’ character, physical health, as well as self-esteem.
Recently, Spotlight Innovation announced that Company research collaborator Professor Kevin Hodgetts was awarded a grant of $300,000 by the nonprofit organization Cure SMA for the project Pre-Clinical Development of LDN-5178 for the Treatment of SMA.
Spotlight Innovation holds an exclusive, worldwide development and commercialization license from Indiana University Innovation and Commercialization Office for LDN-5178 and a group of related compounds. This includes STL-182.
Spotlight Innovation, Inc. (STLT), closed Tuesday's trading session at $0.00822, up 44.2105%, on 1,100 volume with 3 trades. The average volume for the last 3 months is 3,543 and the stock's 52-week low/high is $0.002/$0.034000001.
RepliCel Life Sciences, Inc. (REPCF)
OTCPicks, Greenbackers, Investor Spec Sheet, StockGuru, TheStockAdvisor, 24-7 Stock Alert, Beacon Equity Research, Crazy Carl, Global Equity Report, The Green Baron, Club Penny Stocks Network, Streetwise Reports, InvestorSoup, Penny Stock Explosion, SmallCapReview, Stock Preacher, Penny Stocks Finder, ShazamStocks, and StockHideout reported earlier on RepliCel Life Sciences, Inc. (REPCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
RepliCel Life Sciences, Inc. is a regenerative medicine company listed on the OTC Markets’ OTCQB. The Company concentrates on the development of cell therapies for aesthetic and orthopedic conditions. These include aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. All of its product candidates are based upon RepliCel’s unique technology using cell populations isolated from a patient's healthy hair follicles. RepliCel Life Sciences has its headquarters in Vancouver, British Columbia.
The Company’s product pipeline consists of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, as well as RCH-01 for hair restoration. Currently, RCH-01 is being co-developed with, and under exclusive license by, Shiseido for certain Asian countries. In addition, RepliCel has developed a proprietary injection device RCI-02, optimized for the administration of its products and licensable for use with other dermatology applications.
RepliCel Life Sciences is investing in research that the Company states has the potential to lead to a number of future products. These include other chronic tendinopathies (patellar tendinosis, tennis elbow, golfer’s elbow, rotator cuff); other dermatologic indications (acne scaring, etc.); gingivitis, and allogeneic versions of the Company’s proven autologous cell therapies.
In September 2017, RepliCel Life Sciences announced the timely arrival of its functioning RCI-02 prototypes. These became ready to be showcased to potential end users and licensing partners.
With these prototypes in-hand, the Company is engaging with important opinion leaders and clinical dermatologists to ask for feedback vitally important to aligning successful early adoption of the device, design clinical studies demonstrating its advantages in select applications, and position RepliCel for an anticipated successful launch of an approved next-generation dermal injector in the European market this year.
Recently, RepliCel Life Sciences announced that it signed a Binding Term Sheet with YOFOTO (China) Health Industry Co. Ltd. (YOFOTO) to establish a strategic partnership in Greater China (Mainland China, Hong Kong, Macau, and Taiwan). The deal involves an up-front investment of USD $6,500,000 and potential pre-commercial, non-dilutive milestones payments of another USD $2,800,000.
Moreover, the Term Sheet commits YOFOTO to another USD $1,000,000 in potential post-commercial non-dilutive milestone payments, several million in dedicated program funding in Greater China over the next five years, and future royalty payments calculated on gross product sales in the Territory.
RepliCel Life Sciences, Inc. (REPCF), closed Tuesday's trading session at $0.2187, up 42.013%, on 110 volume with 2 trades. The average volume for the last 3 months is 7,240 and the stock's 52-week low/high is $0.134499996/$0.356999993.
The QualityStocks Company Corner
- MCTC Holdings Inc. (OTC: MCTC)
- SRAX Inc. (NASDAQ: SRAX)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- Sugarmade, Inc. (SGMD)
- Quest Patent Research Corp. (OTCQB: QPRC)
- LiveWire Ergogenics Inc. (OTC: LVVV)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- MustGrow Biologics Corp. (CSE: MGRO)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
MCTC Holdings Inc. (OTC: MCTC)
MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.
With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).
MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):
- Significantly improving bioavailability
- Allowing for ultra-high loading rates
- Enhancing customization of cannabinoid combinations
- Improved dosing precision
- Providing more control in release parameters
MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.
MCTC has now filed four patents on its cannabinoid delivery technology systems:
- The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
- Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
- Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
- Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.
MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).
MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.
MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.
MCTC Holdings Inc. (MCTC), closed Tuesday's trading session at $1.10, up 15.7895%, on 3,211 volume with 11 trades. The average volume for the last 3 months is 9,865 and the stock's 52-week low/high is $0.075000002/$3.00.
- MCTC Files 4th Cannabinoid Delivery Patent – Plurality of Discrete Nanoparticles
- Cannabinoid Based Pharmaceuticals Could Be Most Promising Segment of Cannabis Markets
- MCTC Completes Reverse Share Split Process - Prepares for Additional Cannabinoid Delivery Patent Filings
SRAX Inc. (NASDAQ: SRAX)
Digital marketing and consumer data management technology company SRAX Inc.’s (NASDAQ: SRAX) Founder and CEO Christopher Miglino will host the company’s conference call on November 13 at 1:30 p.m. (PST). The call will detail the company’s Q3 2019 operational and financial summary. Joining Miglino on the call will be COO Kristoffer Nelson; CFO Mike Malone; Vice President of SRAX Shopper George Stella; and Vice President of Research Sales Rick McCrady (http://nnw.fm/7yVqs ).
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $1.56, up 1.2987%, on 25,339 volume with 125 trades. The average volume for the last 3 months is 94,861 and the stock's 52-week low/high is $1.50999999/$5.8499999.
- SRAX Inc. (NASDAQ: SRAX) CEO to Host Q3 2019 Financial Results Conference Call
- SRAX Inc. (NASDAQ: SRAX) Outlines BIGtoken, Company Strategy at Microcap Rodeo Investor Conference
- SRAX, Inc. (NASDAQ: SRAX) to Host November 13 Conference Call to Review Q3 2019 Financial Results
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Automotive technology innovator Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)this morning announced an additional sale of a prototype of its QuadSight(TM) four-camera vision system targeted for the semi-autonomous and autonomous vehicle market. To view the full press release, visit http://nnw.fm/6OfAl.
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed Tuesday's trading session at $1.3233, up 2.2248%, on 3,401 volume with 18 trades. The average volume for the last 3 months is 41,098 and the stock's 52-week low/high is $0.697000026/$2.94000005.
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Receives QuadSight(TM) Prototype Order from Leading South Korean Vehicle Manufacturer
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Eye-Net Mobile Successfully Completes Controlled-Environment Trial for the Connected Car Division of a Leading Global Vehicle Manufacturer
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF). 2018 was a stellar year for cannabis advocates as the green rush of marijuana legalization swept the globe, including California, the world's fifth biggest economy, legalizing recreational marijuana and Canada becoming the first G20 nation to do so; however, 2019 may go down - surprisingly - as the year of a cannabis shake-out. Despite retreating stock prices, some companies are thriving and moving ahead of their peers, achieving brand recognition and increasing recreational sales.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $0.66, up 1.5385%, on 746,573 volume with 422 trades. The average volume for the last 3 months is 526,932 and the stock's 52-week low/high is $0.479999989/$1.7888.
- Supreme's 7ACRES Continues to Impress -- CFN Media
- Lesotho Acts as Gateway to African Cannabis Market
- Supreme Cannabis First Quarter Earnings Release Scheduled for November 14, 2019
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), an oil sands mining and production company with proprietary technology that extracts hydrocarbons from oil sands without the use of water, today announced that it will complete the automation of certain processes at its Asphalt Ridge processing facility in Utah on or around November 20th, 2019. To view the full press release, visit http://nnw.fm/aOBH7.
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Tuesday's trading session at $0.1998, up 4.4706%, on 455,175 volume with 55 trades. The average volume for the last 3 months is 284,130 and the stock's 52-week low/high is $0.112099997/$0.721099972.
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF) Announces Anticipated Automation Completion Date
- Petroteq Announces Agreement to Amend Debentures
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Achieves Continuous Production Level Standards, Touts Crude Oil’s Quality
Sugarmade, Inc. (SGMD)
Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today released full financial performance data for its recent acquisition of BZRTH, a leading hydroponics ecommerce supplier. Per the update, data for the six months ended June 30, 2019, reveal net profitability on sales exceeding $15 million, which represents 25% revenue growth on a sequential six-month period basis. To view the full press release, visit http://cnw.fm/f2N2b. Also today, the company was highlighted in a publication from HempWireNews, examining how, on November 3, the NYPD conducted a drug raid and confiscated 106 pounds of drugs believed to be marijuana. The two officers from Brooklyn 75th Precinct involved in the drug raid tweeted a photo standing next to more than 50 bags of “drugs.” In the tweet, the Precinct congratulated the Day Tour Sector E who were working closely together with FedEx and other law enforcement agencies to confiscate the drugs and arrest the individual transporting the delivery.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.0155, up 10.7143%, on 8,341,649 volume with 208 trades. The average volume for the last 3 months is 5,750,356 and the stock's 52-week low/high is $0.00975/$0.125.
- Sugarmade, Inc. (SGMD) Releases H1 2019 Data for Recent BZRTH Acquisition Revealing Over $15M Sales, 25% Sequential Revenue Growth
- NYPD Erroneously Seizes Hemp Shipment Thinking It Was Marijuana
- Federal Hemp Rules Scare Vermont Farmers
Quest Patent Research Corp. (OTCQB: QPRC)
New York City-based intellectual property (IP) asset management company Quest Patent Research Corp. (OTCQB: QPRC) continues to deliver strong revenue growth while offering shareholders the opportunity to participate in a broad portfolio of dynamic assets (http://nnw.fm/Ebr0t). In a recent interview with NetworkNewsAudio, Quest President and CEO Jon Scahill detailed the company’s focus on creating a liquid marketplace for innovation while protecting the underlying intellectual property.
Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.
Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.
Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:
- IP Valuation
- Structured Licensing Programs
- Patent Prosecution
- Partial or Full Liquidity
- Portfolio Evaluation
- Portfolio Maintenance
- Legal Advisory
- Attorney/Investor Referral
- Patent Acquisition/Liquidation
At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.
Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.
Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.
Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.
Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.
Quest Patent Research Corp. (OTCQB: QPRC), closed Tuesday's trading session at $0.016, even for the day, on 28,225 volume with 3 trades. The average volume for the last 3 months is 254,741 and the stock's 52-week low/high is $0.004499999/$0.039999999.
- Quest Patent Research Corp. (QPRC) Creates Shareholder Value Through a Broad Portfolio of Protected IP Assets
- Quest Patent Research Corp. (QPRC) Subsidiary Alleges Patent Infringement by Apple Inc.
- Quest Patent Research Corp. (QPRC) Committed to Protecting Financial Data System, Takes Apple to Court on Patent Infringement Charges
LiveWire Ergogenics Inc. (OTC: LVVV)
LiveWire Ergogenics Inc. (OTC: LVVV), a forward-thinking company involved in the acquisition, licensing and management of fully compliant turnkey facilities engaged in the production of high-quality cannabis-based products and services in California, is closely watching the progress of the SAFE Banking Act, which once passed on the Senate, would allow banks and credit unions to provide financial services to legal cannabis businesses. With LiveWire’s evolving role in the multibillion-dollar cannabis industry, as it develops its high-quality cannabis brands in the world’s first “Estate Grown Weedery,” the company has a keen interest in the status of legislation related to cannabis and is actively supporting further legalization efforts.
LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.
During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:
PODs and Distribution in Coachella, California
For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.
Estrella Ranch in Paso Robles, California
Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.
The Paso Robles Nursery
LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.
LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.
GHC Ventures Subsidiary
GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.
GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.
LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.
LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.
7X Pure™ Dosing and Verification System
LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.
The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.
The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.
Acquisitions & Operations
To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.
Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.
The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.
LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.
LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.
Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.
As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.
Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.
Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.
Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.
Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.
Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.
LiveWire Ergogenics Inc. (OTC: LVVV), closed Tuesday's trading session at $0.0049, even for the day, on 1,027,470 volume with 24 trades. The average volume for the last 3 months is 1,160,165 and the stock's 52-week low/high is $0.0038/$0.037999998.
- LiveWire Ergogenics Inc. (LVVV) Banking on SAFE Banking Act to Pass and Strengthen Company’s Position in Cannabis Space
- Fire Guts Hemp Processing Facility in Kentucky
- LiveWire Ergogenics Inc. (LVVV) Establishes Research Team to Study CBD-Based Treatments for High-Performance Horses
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. There is a strong possibility of putting recreational marijuana legalization on the 2020 ballot in Florida and this has prompted the House panel to turn to Oregon to learn about the economic, environmental, and other changes that have occurred since the state legalized recreational marijuana in 2015.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Tuesday's trading session at $1.62, off by 3.6632%, on 37,594 volume with 64 trades. The average volume for the last 3 months is 37,478 and the stock's 52-week low/high is $1.43459999/$6.00810003.
- 420 with CNW – Florida House Panel Turns to Oregon for Lessons on Recreational Marijuana
- CBD Brand to Sponsor World Surf League
- 420 with CNW – Strange But True: Marijuana Retrieved from Man’s Nose After 18 Years
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (GGB or the Company) (CSE: GGB) (OTCQB: GGBXF) today announced it will report results for the first quarter fiscal 2020 ending September 28, 2019, after market close on Monday, November 25, 2019. The call and replay archive will be accessible on Green Growth Brands' Investor Relations website.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $1.05, off by 6.25%, on 156,693 volume with 269 trades. The average volume for the last 3 months is 217,832 and the stock's 52-week low/high is $0.843599975/$5.20499992.
- Green Growth Brands to Hold First Quarter Fiscal 2020 Earnings Conference Call on November 26, 2019
- Can You Increase Your Metabolism and Lose Weight Using CBD?
- University of Texas Scientists Develop Rapid Marijuana Test
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how Johns Hopkins Medicine and New York University aren’t the only institutions uncovering the benefits of psilocybin mushrooms. According to a study featured in a 2016 issue of Science Direct, as highlighted by GOOD Magazine, psilocybin mushrooms are effective at treating treatment-resistant depression. Also today, the company was highlighted in a publication from HempWireNews, examining how, on November 3, the NYPD conducted a drug raid and confiscated 106 pounds of drugs believed to be marijuana. The two officers from Brooklyn 75th Precinct involved in the drug raid tweeted a photo standing next to more than 50 bags of “drugs.” In the tweet, the Precinct congratulated the Day Tour Sector E who were working closely together with FedEx and other law enforcement agencies to confiscate the drugs and arrest the individual transporting the delivery. But, it turns out that the confiscated drugs were hemp, not marijuana. The hemp was purchased from Fox Holler Farms in New Haven Vermont by Oren Levy, the owner of Green Angel CBD.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Tuesday's trading session at $0.732, off by 6.1538%, on 1,131,985 volume with 550 trades. The average volume for the last 3 months is 1,059,933 and the stock's 52-week low/high is $0.685999989/$4.38000011.
- Psilocybin Mushrooms Quickly Emerging as Powerful Way to Treat Depression and Addiction
- NYPD Erroneously Seizes Hemp Shipment Thinking It Was Marijuana
- USDA Suggests Hemp Farmers Pay Promotions Fee
MustGrow Biologics Corp. (CSE: MGRO)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics (CSE: MGRO) (OTC: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides and bio-fertility products, today announced that it intends to address a new Fusarium pathogen known as Fusarium wilt Tropical Race 4 (“Fusarium wilt TR4”), a soil-borne disease pathogen afflicting the worldwide banana supply. To view the full press release, visit http://nnw.fm/W2WjK.
MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
MustGrow Biologics Corp. (CSE: MGRO), closed Tuesday's trading session at $0.43, off by 2.27%, on 17,207 volume with 6 trades. The average volume for the last 3 months is 29,497 and the stock's 52-week low/high is $0.25/$0.699999988.
- MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) Intends to Tackle New Fusarium Pathogen Threatening Worldwide Banana Supply
- Canadian Study Finds That Marijuana Could Treat PTSD-Induced Depression
- 420 with CNW – University of Maryland Mulls Offering a Master’s in Marijuana
Nightfood Holdings, Inc. (OTCQB: NGTF)
Wall Street Reporter will be hosting the “NEXT SUPER STOCK - Live!” livestream online-only investor conference on Thursday, November 14, 2019 from 12:30PM-1:30PM EST. CEO Sean Folkson will be discussing Nightfood Holdings, Inc. (OTCQB: NGTF) unique market opportunity, and how NGTF is following the successful playbook of other innovative food & beverage start-up brands, that have become billion dollar giants in recent years. Sean will discuss the company’s expanding national distribution footprint in major supermarket chains, product development, growth strategy, and what’s ahead for 2020. Click here to join: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Tuesday's trading session at $0.246, off by 5.3482%, on 122,590 volume with 38 trades. The average volume for the last 3 months is 144,107 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Wall Street Reporter presents: “NEXT SUPER STOCK Live!” Investor Conference November 14, 2019
- Nightfood CEO Sean Folkson Discusses Nightfood National Rollout and Recent Media Coverage in Advance of November 14 Super Stock Live Conference Presentation
- Nightfood Holdings Inc. (NGTF) Engages Independent Natural Food Brokers to Expand Distribution Reach
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
The next blockbuster in the film-production world could be Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF). The company is set to benefit as subscription video on demand (SVoD) services and “old media” continue to splurge on content. Streaming services such as Amazon Prime, Hulu and Netflix are driving demand for video content from independent film producers. Not to be left behind, established studios are shopping for content too, further increasing demand.
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.
Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.
Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.
The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.
Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.
Management Team with Proven Track Records
Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.
Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.
Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.
Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.
Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.
17-Title Movie Slate — Greenlit
Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.
Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.
The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.
Potential for Breakout Success
Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.
Note: Potential breakout films are not factored into company’s revenue projections.
Base Hits and Home Runs
In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.
Recent Industry Breakout Films Include:
- SAW – $1.2 million budget = $103.9 million in sales
- Pulp Fiction – $8 million budget = $212 million in sales
- My Big Fat Greek Wedding – $5 million budget = $250 million in sales
- Lost in Translation – $4 million budget = $120 million in sales
- Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)
Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.
Recent Wonderfilm Releases
- Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
- Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
- Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
- Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.
Wonderfilm Global Distribution
At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.
Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.
The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.
A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.
Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.
Wonderfilm Business Model
Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.
Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.
Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.
Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.
Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.
Sales overages once contracted presale threshold is surpassed.
The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.
Note: The nature of the film business is that box office revenue lags production up to a couple of years.
$50 Million Wonderfilm Production Fund (WPF):
Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.
The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.
For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.
All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.
Wonderfilm Media Corporation (OTC: WDRFF), closed Tuesday's trading session at $0.149, off by 3.1209%, on 176,862 volume with 28 trades. The average volume for the last 3 months is 47,875 and the stock's 52-week low/high is $0.075099997/$0.504400014.
- Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Eyes Blockbuster Status as SVoD Services, Old Media Splurge
- Why Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Is ‘One to Watch’
- Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Announces US Premier of “Primal” Starring Nicolas Cage on Friday
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Comments on Recent Unauthorized Promotional Activity in Response to OTC Markets Request
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Rivers Rundown: Canopy Rivers Portfolio Companies Prepare for Cannabis 2.0
- ChineseInvestors.com (CIIX) Issues Shareholder Update
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Benefiting from Dramatic Transition to Digital Advertising
- Dama Financial - Enters Strategic Partnership with PayWana
- Earth Science Tech, Inc. (ETST) Marijuana Legalization Bill Introduced in Pennsylvania Senate
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse(R) Reduces Opioid Prescriptions at New Hanover Regional Medical Center
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
- GP Solutions (GWPD) Announces Launch of “Prolific Soilless Growth Medium” and “Prolific Hydro” on Amazon
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Canadian Study Finds That Marijuana Could Treat PTSD-Induced Depression
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Can You Increase Your Metabolism and Lose Weight Using CBD?
- Green Hygienics Holdings Inc. (OTC: GRYN) Employs Efficient Farming Methodology to Address Scalability Challenges
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Colorado Now Has to Modify Its Rules to Meet Federal Requirements
- InsuraGuest Inc. - Inks Deal with Red Lion Inn & Suites to Offer Specialized Insurance Coverage to All Property Guests on Check-in
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) CBD Dispensing Robots Installed in Colorado
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Colorado Now Has to Modify Its Rules to Meet Federal Requirements
- LiveWire Ergogenics Inc. (OTC: LVVV) Establishes Research Team to Study CBD-Based Treatments for High-Performance Horses
- Marijuana Company of America Inc. (MCOA) Federal Hemp Rules Scare Vermont Farmers
- MustGrow Biologics Corp (CSE: MGRO) Canadian Study Finds That Marijuana Could Treat PTSD-Induced Depression
- Neutra Corp. (OTCQB: NTRR) USDA Releases Video Explaining its Draft Hemp Rules
- Nightfood, Inc. (OTCQB: NGTF) Engages Independent Natural Food Brokers to Expand Distribution Reach
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Honored with Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awards
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- OriginClear (OCLND) Water-Treatment Solutions Meet ESG Standards, Boost Property Value
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Successful Completion of Phase 1 Nickel/Cobalt Process Recovery Program
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Agreement to Amend Debentures
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) 420 with CNW – Strange But True: Marijuana Retrieved from Man’s Nose After 18 Years
- Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary’s Officer Presents Initial Findings from Analysis of Landmark UK 100,000 Genomes Project
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Subsidiary Alleges Patent Infringement by Apple Inc.
- Sharing Services Global Corporation (SHRG) Subsidiary Offers Direct Sellers Greater Flexibility, Opportunities
- SinglePoint, Inc. (SING) CEO Discusses Plans for Las Vegas MJ Show on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Report Q3 2019 Financial Results, Host Conference Call
- Spectrum Global Solutions, Inc. (SGSI) Gets Down to Business in Canada
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Why the Marijuana Black Market May Be Hard to Eradicate for Now
- SRAX Inc. (NASDAQ: SRAX) Outlines BIGtoken, Company Strategy at Microcap Rodeo Investor Conference
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate in Two Upcoming Industry Conferences
- Sugarmade, Inc. (SGMD) Federal Hemp Rules Scare Vermont Farmers
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) First Quarter Earnings Release Scheduled for November 14, 2019
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Canadian Marijuana Stocks: Look for These Signs That the Industry Is Turning Around
- Trxade Group Inc. (TRXD) Bonum Health Introduces Revolutionary Online Healthcare Portal
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Poll Shows Americans Still View Marijuana as Safer Than Alcohol and Electronic Cigarettes
- VPR Brands, LP (VPRB) USDA Releases Video Explaining its Draft Hemp Rules
- Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Is ‘One to Watch’
- Xalles Holdings Inc. (XALL) Focusing on Payment Systems, Solutions
- Youngevity International, Inc. (NASDAQ: YGYI) to Host Conference Call to Review 2019 Q3 and Nine-Month Results and Provide Corporate Update
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.